Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy

We aimed to compare the risks of creatine kinase (CK) elevation between patients receiving dolutegravir-based antiretroviral therapy (ART) and those receiving non-integrase strand transfer inhibitor (InSTI)-based ART. HIV-positive patients seeking HIV outpatient care between February 2017 and March...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Guan-Jhou, Sun, Hsin-Yun, Cheng, Aristine, Chuang, Yu-Chung, Huang, Yu-Shan, Lin, Kuan-Yin, Huang, Yi-Chia, Liu, Wen-Chun, Wu, Pei-Ying, Hung, Chien-Ching, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616196/
https://www.ncbi.nlm.nih.gov/pubmed/31261583
http://dx.doi.org/10.1097/MD.0000000000016235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616196/
https://www.ncbi.nlm.nih.gov/pubmed/31261583
http://dx.doi.org/10.1097/MD.0000000000016235

Ejemplares similares